Mark A Goldsmith insider trades: Revolution Medicines (RVMD) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
60 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | RVMD | ↓ Sell | 13,988 | $199.24 | $2.8M | Direct | Sep 18, 2026 (2d) |
| Aug 21, 2026 | RVMD | ↓ Sell | 80,000 | $209.20 | $16.7M | Direct | Aug 25, 2026 (4d) |
| Aug 21, 2026 | RVMD | ↓ Sell | 6,000 | $209.20 | $1.3M | Trust | Aug 25, 2026 (4d) |
| Jun 16, 2026 | RVMD | ↓ Sell | 10,020 | $156.12 | $1.6M | Direct | Jun 18, 2026 (2d) |
| Apr 15, 2026 | RVMD | ↓ Sell | 120,000 | $150.09 | $18.0M | Direct | Apr 17, 2026 (2d) |
| Dec 16, 2025 | RVMD | ↓ Sell | 15,394 | $76.82 | $1.2M | Direct | Dec 18, 2025 (2d) |
| Nov 25, 2025 | RVMD | ↓ Sell | 60,000 | $75.08 | $4.5M | Direct | Nov 26, 2025 (1d) |
| Nov 25, 2025 | RVMD | ↓ Sell | 3,000 | $75.00 | $225K | Trust | Nov 26, 2025 (1d) |
| Nov 18, 2025 | RVMD | ↓ Sell | 20,000 | $70.38 | $1.4M | Direct | Nov 20, 2025 (2d) |
| Nov 12, 2025 | RVMD | ↓ Sell | 20,000 | $65.07 | $1.3M | Direct | Nov 14, 2025 (2d) |
| Nov 7, 2025 | RVMD | ↓ Sell | 30,000 | $60.31 | $1.8M | Direct | Nov 12, 2025 (5d) |
| Oct 17, 2025 | RVMD | ↓ Sell | 20,000 | $52.74 | $1.1M | Direct | Oct 20, 2025 (3d) |
| Sep 16, 2025 | RVMD | ↓ Sell | 13,411 | $45.82 | $615K | Direct | Sep 18, 2025 (2d) |
| Jun 16, 2025 | RVMD | ↓ Sell | 13,496 | $39.83 | $538K | Direct | Jun 18, 2025 (2d) |
| Mar 17, 2025 | RVMD | ↓ Sell | 11,738 | $39.04 | $458K | Direct | Mar 19, 2025 (2d) |
| Dec 16, 2024 | RVMD | ↓ Sell | 11,714 | $45.40 | $532K | Direct | Dec 18, 2024 (2d) |
| Nov 4, 2024 | RVMD | ↓ Sell | 60,000 | $55.48 | $3.3M | Direct | Nov 5, 2024 (1d) |
| Nov 1, 2024 | RVMD | ↓ Sell | 10,000 | $55.02 | $550K | Trust | Nov 5, 2024 (4d) |
| Oct 11, 2024 | RVMD | ↓ Sell | 30,000 | $50.36 | $1.5M | Direct | Oct 15, 2024 (4d) |
| Oct 1, 2024 | RVMD | ↓ Sell | 10,000 | $44.93 | $449K | Direct | Oct 3, 2024 (2d) |
| Sep 16, 2024 | RVMD | ↓ Sell | 11,715 | $44.19 | $518K | Direct | Sep 18, 2024 (2d) |
| Aug 1, 2024 | RVMD | ↓ Sell | 10,000 | $45.88 | $459K | Direct | Aug 2, 2024 (1d) |
| Jul 12, 2024 | RVMD | ↓ Sell | 25,000 | $45.05 | $1.1M | Direct | Jul 16, 2024 (4d) |
| Jul 12, 2024 | RVMD | ↓ Sell | 10,000 | $45.01 | $450K | Trust | Jul 16, 2024 (4d) |
| Jun 17, 2024 | RVMD | ↓ Sell | 11,950 | $37.39 | $447K | Direct | Jun 20, 2024 (3d) |
| Jun 3, 2024 | RVMD | ↓ Sell | 7,500 | $39.99 | $300K | Direct | Jun 5, 2024 (2d) |
| Apr 10, 2024 | RVMD | ↓ Sell | 10,000 | $35.33 | $353K | Trust | Apr 12, 2024 (2d) |
| Apr 10, 2024 | RVMD | ↓ Sell | 7,500 | $35.48 | $266K | Direct | Apr 12, 2024 (2d) |
| Mar 18, 2024 | RVMD | ↓ Sell | 5,788 | $31.58 | $183K | Direct | Mar 20, 2024 (2d) |
| Dec 18, 2023 | RVMD | ↓ Sell | 8,165 | $25.90 | $211K | Direct | Dec 20, 2023 (2d) |
| Sep 18, 2023 | RVMD | ↓ Sell | 8,054 | $31.31 | $252K | Direct | Sep 20, 2023 (2d) |
| Sep 1, 2023 | RVMD | ↓ Sell | 30,000 | $35.05 | $1.1M | Direct | Sep 6, 2023 (5d) |
| Sep 1, 2023 | RVMD | ↓ Sell | 10,000 | $35.04 | $350K | Trust | Sep 6, 2023 (5d) |
| Mar 17, 2022 | RVMD | ↓ Sell | 1,023 | $18.61 | $19K | Direct | Mar 21, 2022 (4d) |
| Dec 17, 2021 | RVMD | ↓ Sell | 1,571 | $24.41 | $38K | Direct | Dec 21, 2021 (4d) |
| Sep 17, 2021 | RVMD | ↓ Sell | 1,531 | $30.02 | $46K | Direct | Sep 21, 2021 (4d) |
| Jun 17, 2021 | RVMD | ↓ Sell | 1,485 | $34.12 | $51K | Direct | Jun 22, 2021 (5d) |
| Mar 1, 2021 | RVMD | ↓ Sell | 5,000 | $46.00 | $230K | Direct | Mar 3, 2021 (2d) |
| Feb 5, 2021 | RVMD | ↓ Sell | 15,000 | $55.00 | $825K | Direct | Feb 8, 2021 (3d) |
| Feb 2, 2021 | RVMD | ↓ Sell | 5,000 | $45.42 | $227K | Direct | Feb 3, 2021 (1d) |
| Dec 21, 2020 | CNST | ↓ Sell | 4,020 | $35.02 | $141K | Owned by Trusts for which Mark A. Goldsm | Dec 28, 2020 (7d) |
| Sep 30, 2020 | RVMD | ↓ Sell | 83,233 | $34.27 | $2.9M | Direct | Sep 30, 2020 (0d) |
| Sep 30, 2020 | RVMD | ↓ Sell | 29,900 | $34.08 | $1.0M | Trust | Sep 30, 2020 (0d) |
| Sep 23, 2020 | RVMD | ↓ Sell | 40,100 | $33.04 | $1.3M | Direct | Sep 23, 2020 (0d) |
| Sep 23, 2020 | RVMD | ↓ Sell | 12,100 | $33.01 | $399K | Trust | Sep 23, 2020 (0d) |
| Sep 18, 2020 | RVMD | ↓ Sell | 43,518 | $30.60 | $1.3M | Direct | Sep 18, 2020 (0d) |
| Sep 18, 2020 | RVMD | ↓ Sell | 12,000 | $31.03 | $372K | Trust | Sep 18, 2020 (0d) |
| Sep 10, 2020 | RVMD | ↓ Sell | 4,499 | $29.00 | $130K | Trust | Sep 11, 2020 (1d) |
| Sep 10, 2020 | RVMD | ↓ Sell | 2,544 | $29.07 | $74K | Direct | Sep 11, 2020 (1d) |
| Sep 8, 2020 | RVMD | ↓ Sell | 900 | $29.05 | $26K | Direct | Sep 10, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RVMD insiders
Open-market trades in the last 12 months
About Mark A Goldsmith's insider trades
Mark A Goldsmith is See Remarks at Revolution Medicines (RVMD). Since Apr 27, 2020, Mark has reported no open-market purchases and 60 sales worth $76.9M on SEC Form 4. In the last 12 months: 11 sales ($50.8M).
Their filings also include option exercises (37 filings), grants and awards (10 filings), gifts (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RVMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.